Endava to Announce Q2 FY2021 Economical Results on February 17, 2021

George T. Taft

LONDON–(Enterprise WIRE)–Endava (NYSE: DAVA), a major subsequent-generation technologies solutions service provider, right now declared it will release results for the next quarter ended December 31, 2020, on Wednesday February 17, 2021 prior to the open of common U.S. current market several hours.

Adhering to the release, John Cotterell, Endava’s CEO and Mark Thurston, Endava’s CFO, will discuss the success in a conference contact commencing at 8:00 am EST.

Convention call accessibility information is:

Participant Toll Cost-free Dial-In Range: (833) 921-1651

Participant Intercontinental Dial-In Amount: (778) 560-2811

Convention ID: 8574719

Webcast: https://traders.endava.com

In addition, a replay will be out there on our investor relations web-site right after the get in touch with.


Endava is a leading next-generation technological innovation expert services provider and can help accelerate disruption by offering quick evolution to enterprises. Making use of dispersed company agile at scale, Endava collaborates with its customers, seamlessly integrating with their teams, catalysing ideation and providing strong remedies. Endava can help its clients turn into electronic, practical experience-driven enterprises by helping them in their journey from notion generation to progress and deployment of products, platforms and alternatives. It companies purchasers in the subsequent industries: Payments and Monetary Services, TMT and “Other,” which involves Buyer Products and solutions, Retail, Mobility and Health care.

Endava had 7,199 workers (including directors) as of September 30, 2020 situated in places of work in North The usa and Western Europe and delivery centres in Romania, Moldova, Bulgaria, Serbia, North Macedonia, Slovenia, Bosnia & Herzegovina, Argentina, Uruguay, Venezuela, and Colombia.

For much more information and facts, visit www.endava.com

Next Post

Aphria, Cannabis Shares Soar as Jazz Pharma to Get GW Pharma

Marijuana shares jumped on Wednesday soon after the information that Jazz Pharmaceuticals  (JAZZ) – Get Report was obtaining cannabinoid-therapeutics organization GW Pharmaceuticals  (GWPH) – Get Report for $7.2 billion of hard cash and inventory. ETFMG Choice Harvest ETF  (MJ) – Get Report, the major cannabis ETF, climbed 11%. GW surged 45%, Aphria  […]